First Tracks Biotherapeutics updates PSU holdings
First Tracks Biotherapeutics, Inc. updated an insider ownership report for Chief Business Officer Benjamin Stone to reflect holdings of 16,667 performance stock units (PSUs), each tied to common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
First Tracks Biotherapeutics, Inc. updated an insider ownership report for Chief Business Officer Benjamin Stone to reflect holdings of 16,667 performance stock units (PSUs), each tied to common stock. The PSUs vest and settle over two years: 50% on March 12, 2027 and 50% on March 12, 2028, subject to his continued service on each vesting date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Performance Stock Unit F1 | -- | -- | -- |
Footnotes (1)
- F1. The PSUs vest and settle over two years; 50% vests on March 12, 2027 and 50% vests on March 12, 2028, subject to the continuing service of the Reporting Person on each vesting date.
Key Figures
Key Terms
Performance Stock Unit financial
PSUs financial
vesting financial
underlying security financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider equity holding does First Tracks Biotherapeutics (TRAX) report for Benjamin Stone?
How do the 16,667 performance stock units for TRAX’s Benjamin Stone vest?
What is the underlying security for Benjamin Stone’s performance stock units at TRAX?
What exercise or conversion price applies to Benjamin Stone’s TRAX performance stock units?
Is the reported 16,667 PSUs position for TRAX a new transaction or a holdings update?
AI-generated analysis. How Rhea-AI works. Not financial advice.